Lithium carbonate has been used in the treatment of tardive dyskinesia (TD) with conflicting results. In this study, six patients with a diagnosis of manic depressive illness were followed in the Affective Disorders Clinic of Douglas Hospital for one year. None of the patients showed improvement of their TD in this study. Possible reasons for this lack of response are discussed.
References
1.
YassaR., AnanthJ.Lithium carbonate in the treatment of movement disorders: a critical review.International Pharmacopsychiatry1980; 15: 301–8.
2.
DalenP.Lithium therapy in Huntington's chorea and tardive dyskinesia.Lanceti: 1973; 107–8.
EhrenargR.H.Lithium and M.R.I.H. in tardive dyskinesia.Lancetii: 1974; 1459–60.
5.
PrangeA., WilsonI.C., MorrisC.E.Preliminary experience with tryptophan and lithium in tardive dyskinesia.Psychopharmacol Bull1973; 9: 36–7.
6.
RedaF.A., EscobarJ.I., ScanlanJ.M.Lithium carbonate in the treatment of tardive dyskinesia.Am J Psychiatry1975; 132: 560–2.
7.
GerlachJ., ThorsenK., MunkvadI.Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.Pharmakopsychiatric1975; 8: 51–6.
8.
SimpsonG.M., BrancheyM.H., LeeJ.M.Lithium in tardive dyskinesia.Pharmakopsychiatric1976; 9: 76–80.
9.
JusA., VilleneuveA., GautierJ.Deanol, lithium and placebo in the treatment of tardive dyskinesia: a double-blind crossover study.Neuropsychobiology1978; 4: 140–9.
10.
MackayA.V.P., SheppardG.P., SabaB.K.Failure of lithium treatment in established tardive dyskinesia.Psychological Medicare1980; 10: 583–7.
11.
JohnsonG., GershonS., MckirnianL.J.Controlled evaluations of lithium and chlorpromazine in the treatment of manic states. An interim report.Compr Psychiatry1968; 9: 563–73.
12.
GuyW.ECDEU Manual of Psychopharmacology. U.S. Dept.of Health, Education and Welfare1976; 197: 534–7.
13.
KlawansH.L., WeinerW.J., NausiedaP.A.The effect of lithium on animal models of tardive dyskinesia.Progress in Neuropsychopharmacology1977; 1: 53–60.
14.
PertA., RosenblattJ.E., SivittC.Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.Science1978; 201: 171–3.
15.
GallagherD.W., PertA., BunneyW.E.Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium.Nature1978; 273: 309–12.
